Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial
Jochen H. Lorch(Northwestern University), Marshall R. Posner(Icahn School of Medicine at Mount Sinai), Ming Tan(University of Maryland, Baltimore), Nicholas J. Sarlis(Incyte (United States)), Daniel Sammartino(Dana-Farber Cancer Institute), J. Fasciano(Morgan Stanley (United States)), Roy B. Tishler(Dana-Farber Cancer Institute), Robert I. Haddad(Georgetown University), Kevin J. Cullen(University of Maryland, Baltimore), Olga Goloubeva(University of Maryland, Baltimore)
Cited by 447
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926